Company Filing History:
3 out of 4,131 
1 out of 1 
1 out of 2,611 
Years Active: 2020-2024
Title: John Svaren: Innovator in Genetic Testing and Neuropathy Research
Introduction
John Svaren is a notable inventor based in Madison, WI (US), recognized for his contributions to genetic testing and neuropathy research. With a total of 4 patents, Svaren has made significant strides in understanding and diagnosing inherited peripheral neuropathy, particularly in dogs and rat models.
Latest Patents
Svaren's latest patents include innovative methods for diagnosing inherited peripheral neuropathy in dogs. These methods and kits test for the presence of a disease-associated genomic variant, which indicates an increased likelihood of the dog developing acquired peripheral neuropathy. This information is crucial for guiding preemptive clinical treatment and selecting dogs for breeding programs. Additionally, he has developed rat models for Charcot-Marie-Tooth disease 2A (CMT2A), which harbor specific mutations that lead to severe, early-onset axonal neuropathy. His research has characterized multiple motor deficits in these models, providing insights into the pathogenesis and potential treatments for CMT2A.
Career Highlights
Throughout his career, Svaren has worked with prominent organizations such as the Wisconsin Alumni Research Foundation and the Charcot-Marie-Tooth Association. His work has not only advanced scientific understanding but has also contributed to practical applications in veterinary medicine and genetic research.
Collaborations
Svaren has collaborated with notable colleagues, including Peter Muir and Susannah Sample, to further his research and innovations in the field of neuropathy.
Conclusion
John Svaren's work in genetic testing and neuropathy research exemplifies the impact of innovation in medical science. His patents and collaborations continue to pave the way for advancements in understanding and treating peripheral neuropathies.